Oncology Virtual Forum

oncology virtual forum

The COVID-19 pandemic disrupted cancer screenings, care delivery and research. But the disease did not slow down. Experts anticipate patients will seek treatment for more advanced-stage cancers than in the past, and oncology centers across the U.S. are making preparations. Clinicians and researchers are also redesigning the cancer patient journey, developing more sophisticated therapies and relying on cutting-edge technology to take cancer treatment to the next level. During this event, oncology leaders from top institutions will gather for high-level discussions about the industry and what will happen next.

Bhavesh Shah, Senior Director of Hematology and Oncology and Specialty Pharmacy at Boston Medical Center

Katie Struck, System Vice President and Chief Administrative Officer of Oncology at Rush University System for Health

Ken Komorny, Chief Pharmacy Officer at Moffitt Cancer Center

Karen Ignagni, CEO of EmblemHealth

Dr. Donna Havens, Dean and Professor at the College of Nursing at Villanova University and Dr. Peter Kaufmann, Associate Dean of Research and Innovation at the College of Nursing at Villanova University

Podcasts

Oncology Virtual Forum | July 26, 2021

Add to Calendar GMail | Outlook | iCal

SPECIAL THANKS TO OUR CORPORATE SPONSORS:

Discussion Topics: • Oncology over the next 5 years: Innovative therapies, telehealth & more • COVID-19 disrupted cancer screenings. Where do we go from here? • How to deliver the cancer care patients really want and thrive in a competitive market Full agenda coming soon!

Craig A Bunnell, MD, MPH, MBA, Chief Medical Officer, Dana-Farber Cancer Institute

Rafael Fonseca, MD, Interim Executive Director, Mayo Clinic Comprehensive Cancer Center; Director for Innovation and Transformational Relationships, Getz Family Professor of Cancer, Distinguished Mayo Investigator

Steven N. Kalkanis, MD, Chief Executive Officer, Henry Ford Medical Group; Chief Academic Officer, Henry Ford Health System; Henry Ford II Chair and Senior Vice President, Henry Ford Health System

Brian J. Bolwell, MD, FACP, Chairman, Taussig Cancer Institute, Professor of Medicine, Cleveland Clinic Lerner School of Medicine

Speaker information coming soon!

Laurie H. Glimcher, MD, President and Chief Executive Officer, Dana-Farber Cancer Institute; Richard and Susan Smith, Professor of Medicine, Harvard Medical School

Ed Edwards, Director of Materials Management, MD Anderson Cancer Center

Ronald Chen, MD, MPH, FASCO, FASTRO, Professor, Joe and Jean Brandmeyer Endowed; Clinical Service Chief, Department of Radiation Oncology; Associate Director of Health Equity, University of Kansas Cancer Center

Ifeyinwa (Ify) Osunkwo, MD, MPH, Director, Sickle Cell Disease Enterprise and Professor of Medicine, Levine Cancer Institute; Professor of Medicine and Pediatrics, Atrium Health

Diana Caragacianu, MD, FACS, Medical Director, Breast Center at Milford Regional Medical Center, Assistant Professor, Breast and Endocrine Surgery, University of Massachusetts Medical School

Donna Royster, Administrative Director, Radiation/Oncology, Levine Cancer Institute, Atrium Health

Tatjana Kolevska, MD, Medical Director, Kaiser Permanente National Cancer Excellence Program; Chair of Oncology and Hematology, The Permanente Medical Group

Carol L. Brown, MD, FACOG, FACS, Surgeon, Senior Vice President and Chief Health Equity Officer; Nicholls-Biondi Chair for Health Equity, Memorial Sloan Kettering

Anthony Ciarolla, MD, MBA, Clinical Assistant Professor, UCLA School of Medicine; Medical Director for Adult Cancer, Long Beach Memorial Medical Center, Long Beach Memorial Medical Center Hospice; President, OPN Healthcare, Inc., Southern California Oncology Associates

Using data insights to transform cancer care delivery

The simple solution infusion centers are adopting to solve common scheduling challenges

Webinars

monday, July 26th, 2021 | 1 - 3 pm ct

JOIN NOW

About

Speakers

Digital Content Hub

Agenda

RSVP NOW

JOIN NOW

VIEW ON DEMAND

thank you to our sponsors

AGENDA

speakers

digital hub

Stay informed with our virtual learning opportunities. Check out our Webinars, Whitepapers, and our E-Newsletters today!

Stay Connected

Jessica Turgon, Principal, ECG Management Consultants Jim Donohue, Associate Principal, ECG Management Consultants Stephanie Hobbs, Associate Principal, ECG Management Consultants Robin Settle, Principal, ECG Management Consultants Linsey Gregory, Director, Payor Market Strategy, University of Kansas Health System

Hot Topics in Cancer Care Delivery and Payment Innovation

1:00 PM CT | Featured Session

View On Demand

Join Now

Learn More

Join now

Craig A Bunnell, MD, MPH, MBA, CMO, Dana-Farber Cancer Institute Rafael Fonseca, MD, Interim Executive Dir., Mayo Clinic Comprehensive Cancer Center; Director for Innovation and Transformational Relationships, Getz Family Prof. of Cancer, Distinguished Mayo Investigator Steven N. Kalkanis, MD, CEO, Henry Ford Medical Group; CAO, Henry Ford Health System; Henry Ford II Chair and Senior VP, Henry Ford Health System Donna Royster, Administrative Dir., Radiation/Oncology, Levine Cancer Institute, Atrium Health

Oncology Over the Next 5 Years: Innovative Therapies, Telehealth & More

1:00 PM CT | Panel discussion

View On Demand

Join Now

Learn More

Join now

Ifeyinwa (Ify) Osunkwo, MD, MPH, Director, Sickle Cell Disease Enterprise and Prof. of Medicine, Levine Cancer Institute; Prof. of Medicine and Pediatrics, Atrium Health Ronald Chen, MD, MPH, FASCO, FASTRO, Prof., Joe and Jean Brandmeyer Endowed; Clinical Service Chief, Department of Radiation Oncology; Associate Director of Health Equity, University of Kansas Cancer Center Anthony Ciarolla, MD, MBA, Clinical Asst. Prof., UCLA School of Medicine; Medical Director for Adult Cancer, Long Beach Memorial Medical Center, Long Beach Memorial Medical Center Hospice; President, OPN Healthcare, Inc., Oncology Associates Laurie H. Glimcher, MD, President and CEO, Dana-Farber Cancer Institute; Prof. of Medicine, Harvard Medical School Diana Caragacianu, MD, FACS, Medical Director, Breast Center at Milford Regional Medical Center, Asst. Prof., Breast and Endocrine Surgery, University of Mass. Medical School

COVID-19 Disrupted Cancer Screenings. Where Do We Go From Here?

1:50 PM CT | Panel discussion

View On Demand

Join Now

Learn More

Join now

Brian J. Bolwell, MD, FACP, Chairman, Taussig Cancer Institute, Prof. of Med., Cleveland Clinic Lerner School of Med. Ed Edwards, Dir. of Materials Management, MD Anderson Cancer Center Laurie H. Glimcher, MD, President and CEO, Dana-Farber Cancer Institute; Richard and Susan Smith, Prof.of Med., Harvard Medical School Tatjana Kolevska, MD, Medical Dir., Kaiser Permanente National Cancer Excellence Program; Chair of Oncology and Hematology, The Permanente Medical Group

How To Deliver the Cancer Care Patients Really Want and Thrive in a Competitive Market

1:50 PM CT | Panel discussion

View On Demand

Join Now

Learn More

Join now

Carol L. Brown, MD, FACOG, FACS, Surgeon, Senior Vice President and Chief Health Equity Officer; Nicholls-Biondi Chair for Health Equity, Memorial Sloan Kettering Moderated by Erica Carbajal, Writer/Reporter, Becker's Healthcare

Fireside Chat: Cancer Health Equity

2:30 PM CT | Fireside chat

View On Demand

Join Now

Learn More

Join now

RSVP NOW

JOIN NOW

VIEW ON DEMAND

DOWNLOAD NOW

How an integrated, digital tumor board tool reduced preparation time and case postponement rates in first, large prospective study

NAVIFY® Tumor Board demonstrated positive impacts in the preparation and conduction of a tumor board during a multiyear study with the Ellis Fischel Cancer Center at Missouri Healthcare. Data was collected prospectively before the use of NAVIFY® Tumor Board (phase 1) through stable integration with the platform (phase 4). Data was collected across the breast, GI, hematopathology and ENT tumor boards looking at the following user groups across the institution: nurse navigators, pathology residents, radiologists and geneticists.

FEATURED whitepaper

Oncology is a complex and unique segment of the US healthcare system, and perhaps no other specialty is as dynamic due to the pace of development and myriad options available to treat various cancers. As the overall cost of treating cancer exceeds $100 billion annually, the US oncology marketplace is under pressure to adapt and innovate to ensure patients receive the care they need while programs remain financially viable. This presentation provides a crash course on the latest trends and “hot topic” issues driving change for cancer centers across the country, including how to enhance payer relationships and fee-for-service reimbursement, pursue transformative payment models and oncology value-based care, optimize key operational performance areas, and better understand market differentiation opportunities through radiation oncology technology or other strategic program initiatives. Join this session to learn what your program must have on the radar going into 2022 and potential strategies to proactively address oncology market changes or best prepare for their future implications.

About

Speakers

Digital Content Hub

Agenda

Hot Topics in Cancer Care Delivery and Payment Innovation